Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

PACS Group, Inc. (PACS) Financial Statements

PACS Group, Inc. (PACS) reported trailing twelve-month revenue of $5.6B (up 15.2% year on year) and net income of $269.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $455.8M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PACSPACS Group, Inc.Follow PACS — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
7.5B
P/E TTM
27.9
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue2.423.114.095.295.55
Gross profit0.560.660.791.161.30
Operating income0.230.210.120.310.41
Pre-tax income0.210.160.100.280.38
Income tax0.060.040.050.090.11
Net income0.150.110.060.190.27
Diluted EPS ($)1.170.880.381.221.71
Diluted shares (bn)0.1290.1290.1490.157—

USD billions · SEC XBRL

PACS Group, Inc. — questions

What is PACS Group, Inc.'s revenue?
$5.6B over the twelve months to 2026-06-30, up 15.2% year on year, from its 10-Q and 10-K filings.
What is PACS Group, Inc.'s net income?
$269.2M over the twelve months to 2026-06-30.
What is PACS Group, Inc.'s free cash flow?
$455.8M over the twelve months to 2026-06-30.
What are PACS Group, Inc.'s diluted earnings per share?
$1.71 over the twelve months to 2026-06-30.

Every figure on this page comes from PACS Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.